[{"address1": "4224 Campus Point Court", "address2": "Suite 210", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 202 6300", "website": "https://www.regulusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph P. Hagan M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 958232, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Crispina  Calsada CPA", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 579300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher Ray Aker J.D.", "age": 63, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 575942, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Preston S. Klassen M.D., M.H.S.", "age": 55, "title": "President, Head of Research & Development and Director", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel J. Penksa", "age": 38, "title": "VP of Finance & Controller", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claire Susan Padgett M.S., M.T., Ph.D.", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rekha  Garg M.D., M.S.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Lee Ph.D.", "title": "Vice President of Translational Medicine", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 3, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 6, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.27, "open": 1.27, "dayLow": 1.27, "dayHigh": 1.39, "regularMarketPreviousClose": 1.27, "regularMarketOpen": 1.27, "regularMarketDayLow": 1.27, "regularMarketDayHigh": 1.39, "payoutRatio": 0.0, "beta": 1.579, "forwardPE": -1.0913223, "volume": 223059, "regularMarketVolume": 223059, "averageVolume": 471793, "averageVolume10days": 301930, "averageDailyVolume10Day": 301930, "bid": 0.9936, "ask": 1.33, "bidSize": 2, "askSize": 1, "marketCap": 86492880, "fiftyTwoWeekLow": 0.83, "fiftyTwoWeekHigh": 3.79, "fiftyDayAverage": 1.3738, "twoHundredDayAverage": 1.66015, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -2878829, "profitMargins": 0.0, "floatShares": 47814443, "sharesOutstanding": 65500100, "sharesShort": 1961451, "sharesShortPriorMonth": 1695685, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0299, "heldPercentInsiders": 0.02207, "heldPercentInstitutions": 0.83411, "shortRatio": 3.4, "shortPercentOfFloat": 0.0381, "impliedSharesOutstanding": 65500100, "bookValue": 1.325, "priceToBook": 0.9966037, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -41628000, "trailingEps": -1.02, "forwardEps": -1.21, "lastSplitFactor": "1:10", "lastSplitDate": 1656460800, "enterpriseToEbitda": 0.065, "52WeekChange": -0.13013697, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 1.3205, "targetHighPrice": 28.0, "targetLowPrice": 3.0, "targetMeanPrice": 10.33333, "targetMedianPrice": 7.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 87309000, "totalCashPerShare": 1.333, "ebitda": -44258000, "totalDebt": 1240000, "quickRatio": 13.469, "currentRatio": 14.145, "debtToEquity": 1.428, "returnOnAssets": -0.42387, "returnOnEquity": -0.72356004, "grossProfits": -22623000, "freeCashflow": -21584124, "operatingCashflow": -35953000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RGLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Regulus Therapeutics Inc.", "longName": "Regulus Therapeutics Inc.", "corporateActions": [], "regularMarketTime": 1740169766, "exchange": "NCM", "messageBoardId": "finmb_36742485", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.9763808, "regularMarketPrice": 1.3205, "marketState": "REGULAR", "cryptoTradeable": false, "regularMarketChange": 0.050500035, "regularMarketDayRange": "1.27 - 1.39", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 471793, "fiftyTwoWeekLowChange": 0.49050003, "fiftyTwoWeekLowChangePercent": 0.5909639, "fiftyTwoWeekRange": "0.83 - 3.79", "fiftyTwoWeekHighChange": -2.4695, "fiftyTwoWeekHighChangePercent": -0.65158314, "fiftyTwoWeekChangePercent": -13.013697, "dividendDate": 1538611200, "earningsTimestampStart": 1742381940, "earningsTimestampEnd": 1742817600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.02, "epsForward": -1.21, "epsCurrentYear": -0.87, "priceEpsCurrentYear": -1.5178161, "fiftyDayAverageChange": -0.053300023, "fiftyDayAverageChangePercent": -0.038797513, "twoHundredDayAverageChange": -0.33965003, "twoHundredDayAverageChangePercent": -0.20458996, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1349789400000, "displayName": "Regulus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]